Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Tempest Therapeutics Inc (NQ: TPST ) 0.9094 -0.0106 (-1.15%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 2,011,740 Open 0.9100 Bid (Size) 0.9090 (2) Ask (Size) 0.9174 (3) Prev. Close 0.9200 Today's Range 0.8900 - 0.9643 52wk Range 0.8800 - 6.000 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News 12 Health Care Stocks Moving In Wednesday's Pre-Market Session October 30, 2024 Via Benzinga Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket October 30, 2024 Via Benzinga Performance YTD -79.38% -79.38% 1 Month -31.62% -31.62% 3 Month -46.82% -46.82% 6 Month -74.31% -74.31% 1 Year -75.42% -75.42% More News Read More 12 Health Care Stocks Moving In Wednesday's Pre-Market Session October 16, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session October 10, 2024 Via Benzinga Why Is Cancer Focused Tempest Therapeutics Stock Trading Higher On Thursday? October 10, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session October 10, 2024 Via Benzinga Tempest Announces Agreement with Roche to Support Advancement of Amezalpat Combination Therapy into First-Line Hepatocellular Carcinoma Pivotal Trial October 10, 2024 From Tempest Therapeutics Via GlobeNewswire Tempest Extends Limited Duration Stockholder Rights Plan October 10, 2024 From Tempest Therapeutics Via GlobeNewswire Tempest Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 20, 2024 From Tempest Therapeutics Via GlobeNewswire Tempest Further Strengthens Leadership Team with Appointment of Sheldon Mullins as Vice President, Regulatory Affairs September 18, 2024 From Tempest Therapeutics Via GlobeNewswire Tempest to Present at the H.C. Wainwright 26th Annual Global Investment Conference September 05, 2024 From Tempest Therapeutics Via GlobeNewswire Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) August 23, 2024 From Tempest Therapeutics Via GlobeNewswire Tempest Announces the Appointment of Troy M. Wagner as Vice President of Quality Assurance August 21, 2024 From Tempest Therapeutics Via GlobeNewswire Why Is Small-Cap Tempest Therapeutics Stock Trading Higher On Thursday? August 15, 2024 Via Benzinga Exposures Product Safety Tempest Announces Successful End-of-Phase 2 Meeting with FDA for Amezalpat (TPST-1120) to Treat First-Line Hepatocellular Carcinoma August 15, 2024 From Tempest Therapeutics Via GlobeNewswire TPST Stock Earnings: Tempest Therapeutics Misses EPS for Q2 2024 August 09, 2024 Via InvestorPlace Tempest Reports Second Quarter 2024 Financial Results and Provides Business Update August 08, 2024 From Tempest Therapeutics Via GlobeNewswire $55M Bet On Archer Aviation? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying July 05, 2024 Via Benzinga Dow Jumps Over 300 Points; Zapp Electric Vehicles Group Shares Spike Higher June 20, 2024 Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Thursday's Intraday Session June 20, 2024 Via Benzinga Why Jabil Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 20, 2024 Via Benzinga Gold Rises 1%; Accenture Shares Surge After Q3 Results June 20, 2024 Via Benzinga What's Going On With Cancer-Focused Tempest Therapeutics Stock On Thursday? June 20, 2024 Via Benzinga Why Is NLS Pharmaceutics (NLSP) Stock Down 23% Today? June 20, 2024 Via InvestorPlace Why Is Avrobio (AVRO) Stock Moving Today? June 20, 2024 Via InvestorPlace Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
